What top creators are saying about Colossal Biosciences(PRIVATE)
Private genetic engineering and de-extinction company.
7 AI-extracted insights from 2 sources — podcasts, YouTube channels, and X/Twitter accounts.
Creator sentiment — last 30 days
Not enough scored insights about Colossal Biosciences in the last 30 days yet.
Top creators covering Colossal Biosciences (PRIVATE)
The 2 sources with the most insights about Colossal Biosciences on Kazuha.
Latest insights about Colossal Biosciences (PRIVATE)
AI-generated insights from podcasts, YouTube videos, and X posts — ordered by most recent.
Saturday, May 23, 2026
Developing artificial egg technology for ex-utero gestation with massive implications for the $1.9 trillion poultry industry.
Monday, April 20, 2026
Positioned as a platform play with significant IP value in 'living products' and potential for high-reward spin-offs in healthcare and environmental sectors.
Wednesday, April 8, 2026
Operates as a platform technology provider and venture studio, creating value through intellectual property and multiple industrial spin-offs.
Tuesday, April 7, 2026
Functions as a venture studio platform for 'living products' with massive industrial potential in materials, health, and conservation.
The company is considered massively undervalued due to its platform nature, high-efficiency CRISPR editing (90%), and potential for high-value spin-offs or a future IPO.
Tuesday, March 17, 2026
Leading emerging theme in synthetic biology and genetic rescue; identified as a high-risk frontier-tech investment.
Saturday, December 13, 2025
Highlighted as a high-growth, 'moonshot' private investment opportunity with rapid valuation growth (from zero to $10 billion in four years) and strong leadership.
Saturday, May 23, 2026
Developing artificial egg technology for ex-utero gestation with massive implications for the $1.9 trillion poultry industry.
Monday, April 20, 2026
Positioned as a platform play with significant IP value in 'living products' and potential for high-reward spin-offs in healthcare and environmental sectors.
Wednesday, April 8, 2026
Operates as a platform technology provider and venture studio, creating value through intellectual property and multiple industrial spin-offs.
Tuesday, April 7, 2026
Functions as a venture studio platform for 'living products' with massive industrial potential in materials, health, and conservation.
The company is considered massively undervalued due to its platform nature, high-efficiency CRISPR editing (90%), and potential for high-value spin-offs or a future IPO.
Tuesday, March 17, 2026
Leading emerging theme in synthetic biology and genetic rescue; identified as a high-risk frontier-tech investment.
Saturday, December 13, 2025
Highlighted as a high-growth, 'moonshot' private investment opportunity with rapid valuation growth (from zero to $10 billion in four years) and strong leadership.
Discussed alongside Colossal Biosciences (PRIVATE)
Other assets that creators frequently mention in the same content as Colossal Biosciences.
Frequently asked
Which podcasters and creators cover Colossal Biosciences (PRIVATE) the most?
The most active sources covering Colossal Biosciences (PRIVATE) on Kazuha are @peterdiamandis, PHD Ventures. Kazuha aggregates AI-extracted insights from podcasts, YouTube channels, and X/Twitter accounts.
How many insights about Colossal Biosciences (PRIVATE) are on Kazuha?
Kazuha has indexed 7 AI-extracted insights about Colossal Biosciences (PRIVATE) from 2 different sources. New insights are added whenever a covered creator publishes a new podcast episode, video, or post.
What other assets do creators discuss alongside Colossal Biosciences (PRIVATE)?
Creators covering Colossal Biosciences (PRIVATE) most frequently also discuss PRIVATE, PRIVATE, SPACE, TSLA, NVDA. See the "Discussed alongside" section above for full asset pages.